Twamev Construction and Infrastructure Limited (NSE:TICL)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	4,845	4,836	5,309	259	366	88
Market Cap Growth	-8.91%	-8.91%	1949.98%	-29.33%	316.67%	102.65%
Enterprise Value	8,203	7,837	8,133	3,241	4,093	3,906
Last Close Price	30.45	31.02	34.45	8.65	13.25	2.60
PE Ratio	8.66	8.64	-	-	-	0.56
PS Ratio	5.71	5.70	10.01	0.28	0.37	0.09
PB Ratio	1.60	1.59	2.14	0.10	0.14	0.03
P/TBV Ratio	1.60	1.60	2.15	0.10	0.14	0.03
P/FCF Ratio	-	-	-	-	-	0.23
P/OCF Ratio	-	-	-	24.90	-	0.23
EV/Sales Ratio	9.67	9.24	15.33	3.45	4.08	3.83
EV/EBITDA Ratio	29.16	27.86	204.36	-	-	55.40
EV/EBIT Ratio	31.19	29.80	492.93	-	-	200.29
EV/FCF Ratio	-181.87	-	-	-	-	10.29
Debt / Equity Ratio	1.12	1.12	1.35	1.32	1.31	1.30
Debt / EBITDA Ratio	12.04	12.04	83.91	-	-	47.90
Debt / FCF Ratio	-	-	-	-	-	8.90
Asset Turnover	0.12	0.12	0.08	0.13	0.15	0.15
Inventory Turnover	1.53	1.53	0.46	1.07	2.24	2.50
Quick Ratio	0.13	0.13	0.15	0.09	0.12	0.14
Current Ratio	0.51	0.51	0.36	0.48	0.37	0.34
Return on Equity (ROE)	20.31%	20.31%	-8.82%	-0.94%	-0.87%	6.22%
Return on Assets (ROA)	2.39%	2.39%	0.15%	-1.20%	-0.58%	0.18%
Return on Capital (ROIC)	2.69%	2.69%	0.18%	-1.44%	-0.66%	0.21%
Return on Capital Employed (ROCE)	7.60%	7.60%	0.60%	-	-	0.70%
Earnings Yield	11.55%	11.58%	-4.19%	-9.31%	-6.17%	178.96%
FCF Yield	-0.93%	-0.93%	-6.70%	-4.44%	-13.10%	431.38%
Buyback Yield / Dilution	-86.97%	-86.97%	-190.59%	-	-	-

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.